Latest news
Clinuvel Pharmaceuticals (OTC: CLVLF) maps vitiligo trial benchmarks and plans - Stock TitanStock Titan · Thu, 30 Jul 2026 10:10:30 GMTCLVLY SEC Filings - Clinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock TitanStock Titan · Thu, 30 Jul 2026 10:10:06 GMTJefferies Maintains CLINUVEL PHARMACEUTICALS LTD(CLVLF.US) With Buy Rating, Raises Target Price to $28.34 - MoomooMoomoo · Wed, 29 Jul 2026 07:00:00 GMTClinuvel Pharmaceuticals (CLVLF) files ASX notice on cessation of securities - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT